OBJECTIVE: Factors associated with mineralization and osteophyte formation in osteoarthritis (OA) are incompletely understood. Genetic polymorphisms of matrix Gla protein (MGP), a mineralization inhibitor, have been associated clinically with conditions of abnormal calcification. We therefore evaluated the relationship of MGP concentrations and polymorphisms at the MGP locus to hand OA. METHODS: Ours was an ancillary study to a 3-year randomized trial assessing the effect of vitamin K supplementation on vascular calcification and bone loss among community-dwelling elders. We studied participants who had serum MGP concentration measured and DNA genotyped for 3 MGP genetic polymorphisms (rs1800802, rs1800801, and rs4236), and who had hand radiographs. We evaluated the cross-sectional associations of serum MGP and the 3 MGP genetic polymorphisms, respectively, with radiographic hand OA using logistic regression with generalized estimating equations, adjusting for potential confounders. RESULTS: Radiographic hand OA in ≥ 1 joint was present in 71% of the 376 participants (mean age 74 years, mean body mass index 28 kg/m(2), 59% women). No significant association between serum MGP concentrations and radiographic hand OA was found [adjusted OR 1.0 (ref), 1.40, 1.21, and 1.21 for quartiles 1-4, respectively]. Homozygosity of the rs1800802 minor allele was associated with 0.56 times lower prevalence of hand OA compared with having ≥ 1 major allele at this locus (95% CI 0.32-0.99, p = 0.046). CONCLUSION: There may be an association between hand OA and genetic polymorphism at the MGP locus that is not reflected by total MGP serum concentrations. Further studies are warranted to replicate and elucidate potential mechanisms underlying these observed associations.
RCT Entities:
OBJECTIVE: Factors associated with mineralization and osteophyte formation in osteoarthritis (OA) are incompletely understood. Genetic polymorphisms of matrix Gla protein (MGP), a mineralization inhibitor, have been associated clinically with conditions of abnormal calcification. We therefore evaluated the relationship of MGP concentrations and polymorphisms at the MGP locus to hand OA. METHODS: Ours was an ancillary study to a 3-year randomized trial assessing the effect of vitamin K supplementation on vascular calcification and bone loss among community-dwelling elders. We studied participants who had serum MGP concentration measured and DNA genotyped for 3 MGP genetic polymorphisms (rs1800802, rs1800801, and rs4236), and who had hand radiographs. We evaluated the cross-sectional associations of serum MGP and the 3 MGP genetic polymorphisms, respectively, with radiographic hand OA using logistic regression with generalized estimating equations, adjusting for potential confounders. RESULTS: Radiographic hand OA in ≥ 1 joint was present in 71% of the 376 participants (mean age 74 years, mean body mass index 28 kg/m(2), 59% women). No significant association between serum MGP concentrations and radiographic hand OA was found [adjusted OR 1.0 (ref), 1.40, 1.21, and 1.21 for quartiles 1-4, respectively]. Homozygosity of the rs1800802 minor allele was associated with 0.56 times lower prevalence of hand OA compared with having ≥ 1 major allele at this locus (95% CI 0.32-0.99, p = 0.046). CONCLUSION: There may be an association between hand OA and genetic polymorphism at the MGP locus that is not reflected by total MGP serum concentrations. Further studies are warranted to replicate and elucidate potential mechanisms underlying these observed associations.
Authors: Christopher J O'Donnell; M Kyla Shea; Paul A Price; David R Gagnon; Peter W F Wilson; Martin G Larson; Douglas P Kiel; Udo Hoffmann; Maros Ferencik; Melvin E Clouse; Matthew K Williamson; L Adrienne Cupples; Bess Dawson-Hughes; Sarah L Booth Journal: Arterioscler Thromb Vasc Biol Date: 2006-09-14 Impact factor: 8.311
Authors: Benjamin D Parker; Leon J Schurgers; Vincent M Brandenburg; Robert H Christenson; Cees Vermeer; Markus Ketteler; Michael G Shlipak; Mary A Whooley; Joachim H Ix Journal: Ann Intern Med Date: 2010-05-18 Impact factor: 25.391
Authors: David T Felson; Michael C Nevitt; Mei Yang; Margaret Clancy; Jingbo Niu; James C Torner; C Elizabeth Lewis; Piran Aliabadi; Burton Sack; Charles McCulloch; Yuqing Zhang Journal: J Rheumatol Date: 2008-09-15 Impact factor: 4.666
Authors: Michael D Crosier; Sarah L Booth; Inga Peter; Bess Dawson-Hughes; Paul A Price; Christopher J O'Donnell; Udo Hoffmann; Matthew K Williamson; Jose M Ordovas Journal: J Nutr Sci Vitaminol (Tokyo) Date: 2009-02 Impact factor: 2.000
Authors: Sarah L Booth; Gerard Dallal; M Kyla Shea; Caren Gundberg; James W Peterson; Bess Dawson-Hughes Journal: J Clin Endocrinol Metab Date: 2008-02-05 Impact factor: 5.958
Authors: K Yagami; J Y Suh; M Enomoto-Iwamoto; E Koyama; W R Abrams; I M Shapiro; M Pacifici; M Iwamoto Journal: J Cell Biol Date: 1999-11-29 Impact factor: 10.539
Authors: Devyani Misra; Sarah L Booth; Irina Tolstykh; David T Felson; Michael C Nevitt; Cora E Lewis; James Torner; Tuhina Neogi Journal: Am J Med Date: 2013-03 Impact factor: 4.965
Authors: M K Shea; S B Kritchevsky; F-C Hsu; M Nevitt; S L Booth; C K Kwoh; T E McAlindon; C Vermeer; N Drummen; T B Harris; C Womack; R F Loeser Journal: Osteoarthritis Cartilage Date: 2014-12-17 Impact factor: 6.576
Authors: D Tuñón-Le Poultel; J B Cannata-Andía; P Román-García; J B Díaz-López; E Coto; C Gómez; M Naves-Díaz; I Rodríguez Journal: Osteoporos Int Date: 2013-11-27 Impact factor: 4.507
Authors: Wouter den Hollander; Cindy G Boer; Deborah J Hart; Michelle S Yau; Yolande F M Ramos; Sarah Metrustry; Linda Broer; Joris Deelen; L Adrienne Cupples; Fernando Rivadeneira; Margreet Kloppenburg; Marjolein Peters; Tim D Spector; Albert Hofman; P Eline Slagboom; Rob G H H Nelissen; André G Uitterlinden; David T Felson; Ana M Valdes; Ingrid Meulenbelt; Joyce J B van Meurs Journal: Ann Rheum Dis Date: 2017-08-30 Impact factor: 19.103